Karyopharm Therapeutics Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for KPTI, updated each market day.
KPTI AI Sentiment
AI sees no strong directional signal for Karyopharm Therapeutics Inc. stock over the next 10 market days.
Prediction date: Sept. 22, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
Sector
Exchange
Market Cap
$40,599,813
Cap Tier
Employees
228
Headquarters
NEWTON, MA
Listed Since
Nov. 6, 2013
Website
KPTI Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
KPTI Volatility
Karyopharm Therapeutics Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
